亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南宏萬德醫藥科技有限公司  

醫藥中間體醫藥中間體化工中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:王倩
  • 電話:86-531-55501998
  • QQ:1773175953
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 布替萘芬
布替萘芬
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
過期 長期有效
更新 2014-10-29 11:04
 
詳細信息
 英文名N-(4-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride
別名***布替萘芬; N-(4-叔丁基苯基)-N-甲基-1-萘甲胺***
 
產品名稱Butenafine hydrochloride
分子式C23H27N.HCl;C23H28ClN
分子量353.19
CAS 登錄號101827-46-7
Name   Butenafine hydrochloride 
Synonyms   N-(4-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride 
 
Molecular Structure    
  
Molecular Formula   C23H27N.HCl;C23H28ClN 
Molecular Weight   353.19 
CAS Registry Number   101827-46-7 
©2025 濟南宏萬德醫藥科技有限公司 版權所有   技術支持:化工網   訪問量:3692  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |